The largest database of trusted experimental protocols

Pimecrolimus

Manufactured by Selleck Chemicals

Pimecrolimus is a pharmaceutical compound used in the production of various laboratory equipment. It functions as an immunosuppressant agent, inhibiting the activation and proliferation of T-cells. The core function of Pimecrolimus is to serve as a key component in the development of specialized lab equipment for research and analytical purposes.

Automatically generated - may contain errors

2 protocols using pimecrolimus

1

VZV Glycoprotein Fusion Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Tacrolimus (FK506) (Selleckchem), pimecrolimus (Selleckchem), sirolimus (Selleckchem), and ionomycin (Alomone labs) were all dissolved in DMSO (Sigma Aldrich). Activity of the compounds on VZV gB/gH-gL mediated cell fusion were evaluated by stable reporter fusion assay as described previously [28 (link)]. Briefly, CHO-DSP1 or MeWo-DSP1 cells transfected with equal quantities of pCAGGS-gB, pME18S-gH[TL], and pcDNA3.1-gL plasmids using Lipofectamine 2000 were harvested at 6 hrs post-transfection, and mixed with MeWo-DSP2 cells in the presence of various concentrations of the compounds prepared in two-fold serial dilutions, ranging from 10 μM to 1.25 μM. Co-culture of cells were seeded into Nunc MicroWell 96-well Optical-Bottom Plates (ThermoFisher) and incubated for 48 hrs. The activity of Renilla luciferase was read immediately after adding substrate h-Coelenterazine (Nanolight Technology). Transfection with only vehicle plasmids pcDNA3.1 (+) and pME18S, or pcDNA3.1 (+), pME18S and pCAGGS-gB served as negative control. Cell viability was measured using CellTiter-Glo Luminescent substrate (Promega). Luminescence signal was recorded using Synergy H1 Hybrid Multi-Mode Reader (BioTek). Experiments were performed at least in triplicate.
+ Open protocol
+ Expand
2

Human ex vivo skin cytokine stimulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human ex vivo skin culture, processed as above, was placed in Transwells. Target specific inhibitors were applied basolaterally, each at 1 µM for overnight treatment (ca ~16 h) prior to stimulation (Clobetasol propionate, Selleck Chemical # S2584, Batch No 02; Calcitriol, Cayman Chemical #71820, Batch No 0495381-30; Pimecrolimus, Selleck Chemical #S5004, Batch No 03; Crisaborole, MedChem Express #AN-2728, lot #16616; Tofacitinib, ApexBio #477600-75-2, Batch No 01).The next morning, fresh media containing inhibitors and cytokine cocktail stimulation were added basolaterally for 24 h stimulation. Tissue was harvested and processed for RNA isolation and qRT-PCR.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!